5,6-dihydroxytryptamine has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bader, M; Peter, JU; Walther, DJ | 1 |
| Krieger, DT | 1 |
1 review(s) available for 5,6-dihydroxytryptamine and Lung Neoplasms
| Article | Year |
|---|---|
Rhythms of ACTH and corticosteroid secretion in health and disease, and their experimental modification.
Topics: 5,6-Dihydroxytryptamine; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Animals, Newborn; Blindness; Carcinoma, Bronchogenic; Central Nervous System Diseases; Circadian Rhythm; Cushing Syndrome; Darkness; Food Deprivation; Humans; Hydrocortisone; Hydroxydopamines; Light; Liver Diseases; Lung Neoplasms; Male; Mental Disorders; Rats; Time Factors | 1975 |
1 other study(ies) available for 5,6-dihydroxytryptamine and Lung Neoplasms
| Article | Year |
|---|---|
7-Hydroxytryptophan, a novel, specific, cytotoxic agent for carcinoids and other serotonin-producing tumors.
Topics: 5,6-Dihydroxytryptamine; 5,7-Dihydroxytryptamine; Animals; Antineoplastic Agents; Carcinoid Tumor; Carcinoma, Small Cell; COS Cells; Humans; Lung Neoplasms; Pancreatic Neoplasms; Serotonin; Tryptophan; Tryptophan Hydroxylase; Tumor Cells, Cultured | 2002 |